...Eroski S. Coop's EBITDA slightly contracted in the first half of 2024 amid a challenging operating environment, after a strong fiscal year 2023 (ending Jan. 31, 2024). Eroski reported gross sales of 2,607 million for the first half of fiscal 2024, a 3.2% increase from the same period in 2023. However, the company's adjusted EBITDA of 256 million for the same period was 4.0% lower than for first-half 2023, implying a dilution of about 80 basis points of adjusted EBITDA margin to 9.8%. This slight dilution follows a very strong fiscal year 2023, when the company outperformed our base-case expectations of revenue and EBITDA, which reached 530 million. We expect similar full-year EBITDA for fiscal 2024, as the second half of the year...